The effect of early initiation of antiretroviral treatment in infants on pediatric AIDS mortality in South Africa: A model-based analysis

Pediatric Infectious Disease Journal

Volumn 31, Issue 5, 2012, Pages 474-480

  Johnson, Leigh F ^a   Davies, Mary Ann ^a   Moultrie, Harry ^b,c   Sherman, Gayle G ^c   Bland, Ruth M ^d,e   Rehle, Thomas M ^f   Dorrington, Rob E ^a   Newell, Marie Louise ^d,g  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

^f HUMAN SCIENCES RESEARCH COUNCIL   (South Africa)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Antiretroviral treatment; HIV AIDS; Pediatric; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; AIDS PATIENT; ARTICLE; CHILD; CHILDHOOD MORTALITY; CONFIDENCE INTERVAL; DISEASE COURSE; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; MATHEMATICAL MODEL; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SIMULATION; SOUTH AFRICA; SURVIVAL RATE;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MODELS, BIOLOGICAL; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; SOUTH AFRICA; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 84860250560     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182456ba2     Document Type: Article

References (54)

1. Marston M, Becquet R, Zaba B, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from sub-Saharan Africa. Int J Epidemiol. 2011;40:385-396.
2. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J. 2007;26:519-526.
3. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach, 2006. Geneva, Switzerland; 2007. Available at: http://www.who.int/hiv/pub/guidelines/art/en/Accessed January 26, 2009.
4. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359:2233-2244.
5. World Health Organization. Antiretroviral therapy for HIV infection in infants and children: towards universal access. 2010. Available at: http://whqlibdoc.who.int/publications/2010/9789241599801-eng.pdf. Accessed December 13, 2010.
6. Peltzer K, Mlambo G. Factors affecting HIV viral testing of infants in the context of mother-to-child transmission. Acta Paediatr. 2010;99:590-596.
7. Gray GE, Urban M, Chersich MF, et al. A randomized trial of two postexposure prophylaxis regimens to reduce mother-to-child HIV-1 transmission in infants of untreated mothers. AIDS. 2005;19:1289-1297.
8. Coetzee D, Hilderbrand K, Boulle A, et al. Effectiveness of the first districtwide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull WHO. 2005;83:489-494.
9. Mphatswe W, Blanckenberg N, Tudor-Williams G, et al. High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS. 2007;21:1253-1261.
10. Fenner L, Brinkhof MW, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immun Defic Syndr. 2010;54:524-532.
11. Kuhn L, Abrams EJ, Weedon J, et al. Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods. J Infect Dis. 2000;182:104-111.
12. Ferrand RA, Luethy R, Bwakura F, et al. HIV infection presenting in older children and adolescents: a case series from Harare, Zimbabwe. Clin Infect Dis. 2007;44:874-878.
13. Ferrand RA, Corbett EL, Wood R, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS. 2009;23:2039-2046.
14. Weigel R, Estill J, Egger M, et al. Mortality and loss to follow-up in the first year of ART: Malawi national ART programme. AIDS. 2012;26:365-373.
15. Bakanda C, Birungi J, Mwesigwa R, et al. Survival of HIV-infected adolescents on antiretroviral therapy in Uganda: findings from a nationally representative cohort in Uganda. PLoS One. 2011;6:e19261.
16. Nachega JB, Hislop M, Nguyen H, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in Southern Africa. J Acquir Immun Defic Syndr. 2009;51:65-71.
17. Williams PL, Storm D, Montepiedra G, et al. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection. Pediatrics. 2006;118:e1745-e1757.
18. Jaspan H, Li R, Johnson L, Bekker LG. The emerging need for adolescentfocused HIV care in South Africa. South Afr J HIV Med. 2009;10:9-11.
19. Department of Health. Guidelines for the management of HIV in children. 2nd ed; 2010. Available at: http://www.doh.gov.za/docs/index.html. Accessed March 6, 2011.
20. Dorrington RE, Johnson LF, Bradshaw D, et al. The Demographic Impact of HIV/AIDS in South Africa. National and Provincial Indicators for 2006. Cape Town: Centre for Actuarial Research, South African Medical Research Council and Actuarial Society of South Africa; 2006. Available at: http://www.commerce.uct. ac.za/Research-Units/CARE/RESEARCH/PAPERS/ASSA2003Indicators.pdf. Accessed August 3, 2011.
21. Day C, Monticelli F, Barron P, et al. District Health Barometer: Year 2008/09. Durban: Health Systems Trust; 2010. Available at: http://www.hst. org.za/publications/864. Accessed June 25, 2010.
22. Johnson LF. A model of paediatric HIV in South Africa. Cape Town: Centre for Infectious Disease Epidemiology and Research, University of Cape Town; 2010. Available at: http://webdav.uct.ac.za/depts/epi/publications/documents/ Paediatric-HIV-modelling5.pdf. Accessed February 23, 2011.
23. Makeham WM. On the law of mortality. J Inst Actuaries. 1867;13:325-358.
24. Charlebois ED, Ruel TD, Gasasira AF, et al. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy. J Acquir Immun Defic Syndr. 2010;55:330-335.
25. Diaz C, Hanson C, Cooper ER, et al. Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS). J Acquir Immun Defic Syndr. 1998;18:221-228.
26. Blanche S, Newell ML, Mayaux MJ, et al. Morbidity and mortality in European children vertically infected by HIV-1. J Acquir Immun Defic Syndr. 1997;14:442-450.
27. Fox MP, Brooks D, Kuhn L, et al. Reduced mortality associated with breastfeeding-acquired HIV infection and breast-feeding among HIV-infected children in Zambia. J Acquir Immun Defic Syndr. 2008;48:90-96.
28. Sutcliffe CG, Scott S, Mugala N, et al. Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis. 2008;47:837-844.
29. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243.
30. Cross Continents Collaboration for Kids. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. AIDS. 2008;22:97-105.
31. Hussey GD, Reijnhart RM, Sebens AM, et al. Survival of children in Cape Town known to be vertically infected with HIV-1. S Afr Med J. 1998;88:554-558.
32. Davies M, Keiser O, Technau K, et al. Outcomes of the South African national antiretroviral treatment programme for children: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
33. Bera E, Jwacu N, Pauls F, et al. Risk factors for perinatal HIV-1 transmission in pregnant women requiring lifelong antiretroviral therapy: a longitudinal study at a tertiary hospital in South Africa. S Afr J Obstet Gynaecol. 2010;16:6-13.
34. van der Merwe K, Chersich MF, Technau K, et al. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immun Defic Syndr. 2006;43:577-581.
35. Rollins N, Mzolo S, Moodley T, et al. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23:1851-1857.
36. Adam MA, Johnson LF. Estimation of adult antiretroviral treatment coverage in South Africa. S Afr Med J. 2009;99:661-667.
37. Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, HIV Incidence, Behaviours and Communication Survey, 2005. Cape Town: HSRC Press; 2005. Available at: http://www.hsrcpress.ac.za. Accessed December 1, 2005.
38. Shisana O, Simbayi LC, Rehle T, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2008: The Health of Our Children. Cape Town, South Africa; 2010. Available at: http://www.hsrc. ac.za/Research-Publication-21767.phtml. Accessed August 7, 2010.
39. Raftery AE, Bao L. Estimating and projecting trends in HIV/AIDS generalized epidemics using incremental mixture importance sampling. Biometrics. 2010;66:1162-1173.
40. Bourne DE, Thompson M, Brody LL, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101-106.
41. Boulle A, Thompson ML, Laubscher R, et al. Provincial differences in age distributions of infant deaths in South Africa: evidence of the impact of antiretroviral interventions? South Afr J HIV Med. 2011;39:20-23.
42. Kellerman S, Essajee S. HIV testing for children in resource-limited settings: what are we waiting for? PLoS Med. 2010;7:e1000285.
43. Zijenah LS, Moulton LH, Iliff P, et al. Timing of mother-to-child transmission of HIV-1 and infant mortality in the first 6 months of life in Harare, Zimbabwe. AIDS. 2004;18:273-280.
44. Sherman G, Lilian R. Early infant diagnosis of HIV infection in South Africa: 2008 to 2010. 2011.
45. Bock P, Boulle A, White C, Osler M, Eley B. Provision of antiretroviral therapy to children within the public sector of South Africa. Trans R Soc Trop Med Hyg. 2008;102:905-911.
46. Fatti G, Grimwood A, Bock P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS One. 2010;5:e12888.
47. Stover J, Johnson P, Hallett T, et al. The Spectrum projection package: improvements in estimating incidence by age and sex, mother-to-child transmission, HIV progression in children and double orphans. Sex Transm Infect. 2010;86(suppl 2):ii16-ii21.
48. Little K, Newell ML, Luo C, et al. Estimating the number of vertically HIVinfected children eligible for antiretroviral treatment in resource-limited settings. Int J Epidemiol. 2007;36:679-687.
49. Siler W. A competing-risk model for animal mortality. Ecology. 1979;60:750-757.
50. van Kooten Niekerk NK, Knies MM, Howard J, et al. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy. J Trop Pediatr. 2006;52:3-11.
51. Statistics South Africa. Mortality and causes of death in South Africa, 2008: Findings from death notification. Pretoria; 2010. Available at: http://www.statssa.gov.za/publications/statsdownload.asp?PPN?P0309.3& SCH?4790. Accessed 28 Nov 2010.
52. Janssen N, Ndirangu J, Newell ML, et al. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2010;95:414-421.
53. Fatti G, Bock P, Grimwood A, et al. Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. J Int AIDS Soc. 2010;13:46.
54. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immun Defic Syndr. 2008;49:523-531.